Search research articles
Contact Us
Filters
Showing results (51-60 of 96) with videos related to
Page
of 10
Sort By:
Biochimica Et Biophysica Acta
|
September 27, 2002
A replicating module as the unit of mitochondrial structure and functioning
Roderick A Capaldi, Robert Aggeler, Robert Gilkerson, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
September 28, 2023
A Mechanism Underpinning the Bioenergetic Metabolism-Regulating Function of Gold Nanocatalysts
Zixin Wang, Alexandre Henriques, Laura Rouvière, et al.
Biochimica Et Biophysica Acta
|
December 21, 2010
XPC silencing in normal human keratinocytes triggers metabolic alterations through NOX-1 activation-mediated reactive oxygen species
Hamid Reza Rezvani, Rodrigue Rossignol, Nsrein Ali, et al.
The Journal of Clinical Investigation
|
December 3, 2010
XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas
Hamid Reza Rezvani, Arianna L Kim, Rodrigue Rossignol, et al.
Cell Death & Disease
|
April 28, 2026
DHODH inhibition suppresses cutaneous squamous cell carcinoma growth by the induction of differentiation through perturbation of the cellular redox balance
Ferial Khalife, Elodie Muzotte, Fatima Naji, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 9, 2016
High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy
Toshiyuki Imasawa, Emilie Obre, Nadège Bellance, et al.
Cell Metabolism
|
April 23, 2013
Rheb regulates mitophagy induced by mitochondrial energetic status
Su Melser, Etienne Hébert Chatelain, Julie Lavie, et al.
Oncotarget
|
August 1, 2015
The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism
Nerea Allende-Vega, Ewelina Krzywinska, Stefania Orecchioni, et al.
Oncogenesis
|
September 26, 2019
UVB-induced DHODH upregulation, which is driven by STAT3, is a promising target for chemoprevention and combination therapy of photocarcinogenesis
Mohsen Hosseini, Léa Dousset, Pauline Michon, et al.
International Journal of Molecular Sciences
|
November 13, 2021
Olaparib Is a Mitochondrial Complex I Inhibitor That Kills Temozolomide-Resistant Human Glioblastoma Cells
Luca X Zampieri, Martina Sboarina, Andrea Cacace, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 96) with videos related to
Sort By:
Page
of 10
Biochimica Et Biophysica Acta
|
September 27, 2002
A replicating module as the unit of mitochondrial structure and functioning
Roderick A Capaldi, Robert Aggeler, Robert Gilkerson, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
September 28, 2023
A Mechanism Underpinning the Bioenergetic Metabolism-Regulating Function of Gold Nanocatalysts
Zixin Wang, Alexandre Henriques, Laura Rouvière, et al.
Biochimica Et Biophysica Acta
|
December 21, 2010
XPC silencing in normal human keratinocytes triggers metabolic alterations through NOX-1 activation-mediated reactive oxygen species
Hamid Reza Rezvani, Rodrigue Rossignol, Nsrein Ali, et al.
The Journal of Clinical Investigation
|
December 3, 2010
XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas
Hamid Reza Rezvani, Arianna L Kim, Rodrigue Rossignol, et al.
Cell Death & Disease
|
April 28, 2026
DHODH inhibition suppresses cutaneous squamous cell carcinoma growth by the induction of differentiation through perturbation of the cellular redox balance
Ferial Khalife, Elodie Muzotte, Fatima Naji, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 9, 2016
High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy
Toshiyuki Imasawa, Emilie Obre, Nadège Bellance, et al.
Cell Metabolism
|
April 23, 2013
Rheb regulates mitophagy induced by mitochondrial energetic status
Su Melser, Etienne Hébert Chatelain, Julie Lavie, et al.
Oncotarget
|
August 1, 2015
The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism
Nerea Allende-Vega, Ewelina Krzywinska, Stefania Orecchioni, et al.
Oncogenesis
|
September 26, 2019
UVB-induced DHODH upregulation, which is driven by STAT3, is a promising target for chemoprevention and combination therapy of photocarcinogenesis
Mohsen Hosseini, Léa Dousset, Pauline Michon, et al.
International Journal of Molecular Sciences
|
November 13, 2021
Olaparib Is a Mitochondrial Complex I Inhibitor That Kills Temozolomide-Resistant Human Glioblastoma Cells
Luca X Zampieri, Martina Sboarina, Andrea Cacace, et al.
Page
of 10